Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018009047) A DNA VACCINE FOR PREVENTING AND TREATING HSV-2 INFECTION
Latest bibliographic data on file with the International BureauSubmit observation

Pub. No.: WO/2018/009047 International Application No.: PCT/KR2017/010566
Publication Date: 11.01.2018 International Filing Date: 25.09.2017
IPC:
C07K 14/005 (2006.01) ,A61K 39/00 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005
from viruses
01
DNA viruses
03
Herpetoviridae, e.g. pseudorabies virus
05
Epstein-Barr virus
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
Applicants:
SL VAXIGEN, INC. [KR/KR]; 700, Daewangpangyo-ro, Bundang-gu Seongnam-si Gyeonggi-do 13488, KR
Inventors:
SEO, Yong-Bok; KR
SHIN, Ju-A; KR
Agent:
HAN, Yun Ho; KR
Priority Data:
10-2016-012514928.09.2016KR
Title (EN) A DNA VACCINE FOR PREVENTING AND TREATING HSV-2 INFECTION
(FR) VACCIN À ADN POUR LA PRÉVENTION ET LE TRAITEMENT DE L'INFECTION PAR LE HSV-2
Abstract:
(EN) The present disclosure relates to a novel DNA vaccine for preventing and treating herpes simplex virus-2 (HSV-2) infection, and provides a polynucleotide encoding a shuffled UL39 protein; a vector containing the polynucleotide; and a DNA vaccine composition containing the vector.
(FR) La présente invention concerne un nouveau vaccin à ADN pour la prévention et le traitement du virus de l'herpès simplex-2 (HSV-2), ainsi qu'un polynucléotide codant pour une protéine UL39 modifiée; un vecteur contenant le polynucléotide; et une composition de vaccin à ADN contenant le vecteur.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
ID2018/05131CN108419437